Type 1 diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
Current intervention as of 02/12/2019:
Randomisation:
After the participants are identified, patients are randomised to an intervention group or to a waiting list control group, using randomisation en
Sponsors
Uppsala University Department of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-25 years 2. Diagnosis of type 1 diabetes
Exclusion criteria
Exclusion criteria: 1. Severe depression, eating disorder or other serious mental illness 2. Alcohol/drug abuse 3. Severe diabetes late complications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c measured in blood taken at baseline, 6 months, 12 months and (for the wait-list group only) 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 02/12/2019: 1. Patient's satisfaction with their diabetes treatment assessed using the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at baseline, 6 months, 12 months and (for the wait-list group only) 18 months 2. Patient's assessment of their physical health, mental and emotional wellbeing and quality of life assessed using the 'Ta tempen på din hälsa [Take the temp of your health]' questionnaire at baseline, 6 months, 12 months and (for the wait-list group only) 18 months 3. Change in patient's satisfaction with their diabetes treatment assessed using the Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) at 12 months for the intervention group and 18 months for the wait-list group 4. Participant's views on the virtual care intervention assessed using qualitative analysis of interviews with a sample of participants before and at the end of the intervention Previous secondary outcome measures: 1. Patient's satisfaction with their diabetes treatment assessed using the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at baseline, 6 months, 12 months and (for the wait-list group only) 18 months 2. Patient's assessment of their physical health, mental and emotional wellbeing and quality of life assessed using the 'Ta tempen på din hälsa [Take the temp of your health]' questionnaire at baseline, 6 months, 12 months and (for the wait-list group only) 18 months 3. Change in patient's satisfaction with their diabetes treatment assessed using the Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) at 12 months for the intervention group and 18 months for the wait-list group | — |
Countries
Sweden
Contacts
Public ContactJaneth Leksell
Outcome results
None listed